Rekah Pharmaceutical Industry Ltd (REKA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Rekah Pharmaceutical Industry Ltd (REKA) has a cash flow conversion efficiency ratio of 0.037x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA5.27 Million ≈ $14.13K USD) by net assets (ILA144.21 Million ≈ $386.62K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Rekah Pharmaceutical Industry Ltd net asset quality index to measure how much of total assets are equity-financed.
Rekah Pharmaceutical Industry Ltd - Cash Flow Conversion Efficiency Trend (2004–2025)
This chart illustrates how Rekah Pharmaceutical Industry Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Rekah Pharmaceutical Industry Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Rekah Pharmaceutical Industry Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Rekah Pharmaceutical Industry Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SHL Telemedicine Ltd American Depositary Shares
NASDAQ:SHLT
|
-0.004x |
|
Comms Group Ltd
AU:CCG
|
0.068x |
|
Smart Logistics Global Limited Ordinary Shares
NASDAQ:SLGB
|
-0.051x |
|
Dierig Holding AG
XETRA:DIE
|
0.070x |
|
Beauty Community Public Company Limited
BK:BEAUTY
|
0.033x |
|
Mepet Metro Petrol ve Tesisleri Sanayi Ticaret AS
IS:MEPET
|
-0.032x |
|
Wellbiotec Co. Ltd.
KO:010600
|
-0.033x |
|
Q linea AB
ST:QLINEA
|
-0.099x |
Annual Cash Flow Conversion Efficiency for Rekah Pharmaceutical Industry Ltd (2004–2025)
The table below shows the annual cash flow conversion efficiency of Rekah Pharmaceutical Industry Ltd from 2004 to 2025. For the full company profile with market capitalisation and key ratios, see Rekah Pharmaceutical Industry Ltd market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ILA144.21 Million ≈ $386.62K |
ILA12.95 Million ≈ $34.72K |
0.090x | -45.20% |
| 2024-12-31 | ILA161.98 Million ≈ $434.25K |
ILA26.54 Million ≈ $71.16K |
0.164x | -10.07% |
| 2023-12-31 | ILA155.59 Million ≈ $417.12K |
ILA28.35 Million ≈ $76.01K |
0.182x | -24.28% |
| 2022-12-31 | ILA162.08 Million ≈ $434.53K |
ILA39.00 Million ≈ $104.56K |
0.241x | +96.73% |
| 2021-12-31 | ILA173.06 Million ≈ $463.98K |
ILA21.17 Million ≈ $56.75K |
0.122x | +79.52% |
| 2020-12-31 | ILA165.59 Million ≈ $443.94K |
ILA11.28 Million ≈ $30.25K |
0.068x | -68.81% |
| 2019-12-31 | ILA155.22 Million ≈ $416.13K |
ILA33.91 Million ≈ $90.92K |
0.218x | +90.45% |
| 2018-12-31 | ILA150.66 Million ≈ $403.91K |
ILA17.28 Million ≈ $46.34K |
0.115x | -30.28% |
| 2017-12-31 | ILA144.62 Million ≈ $387.73K |
ILA23.80 Million ≈ $63.80K |
0.165x | -23.69% |
| 2016-12-31 | ILA105.86 Million ≈ $283.81K |
ILA22.82 Million ≈ $61.19K |
0.216x | +359.22% |
| 2015-12-31 | ILA123.66 Million ≈ $331.52K |
ILA5.81 Million ≈ $15.57K |
0.047x | +172.04% |
| 2014-12-31 | ILA77.06 Million ≈ $206.59K |
ILA1.33 Million ≈ $3.57K |
0.017x | -88.28% |
| 2013-12-31 | ILA79.51 Million ≈ $213.17K |
ILA11.71 Million ≈ $31.38K |
0.147x | -26.12% |
| 2012-12-31 | ILA71.17 Million ≈ $190.79K |
ILA14.18 Million ≈ $38.02K |
0.199x | +88.75% |
| 2010-12-31 | ILA63.78 Million ≈ $171.00K |
ILA6.73 Million ≈ $18.05K |
0.106x | -73.98% |
| 2009-12-31 | ILA64.15 Million ≈ $171.99K |
ILA26.03 Million ≈ $69.78K |
0.406x | +261.86% |
| 2008-12-31 | ILA58.62 Million ≈ $157.17K |
ILA6.57 Million ≈ $17.62K |
0.112x | -39.57% |
| 2007-12-31 | ILA67.10 Million ≈ $179.88K |
ILA12.45 Million ≈ $33.38K |
0.186x | +155.46% |
| 2005-12-31 | ILA58.85 Million ≈ $157.77K |
ILA4.27 Million ≈ $11.46K |
0.073x | -80.15% |
| 2004-12-31 | ILA48.86 Million ≈ $131.00K |
ILA17.87 Million ≈ $47.92K |
0.366x | -- |
About Rekah Pharmaceutical Industry Ltd
Rekah Pharmaceutical Industry Ltd. engages in the manufacture, marketing, sale, and distribution of pharmaceuticals, cosmetics, vitamins and nutritional supplements, and medical devices in Israel. The company offers steroids, antibiotics, and ophthalmic products, as well as dermo-cosmetics products. Its portfolio of products comprise Rx and OTC drugs, and medical devices used in various therapeut… Read more